• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ATLN

    Atlantic International Corp.

    Subscribe to $ATLN
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    IPO Year: 2024

    Exchange: NASDAQ

    Recent Analyst Ratings for Atlantic International Corp.

    DatePrice TargetRatingAnalyst
    See more ratings

    Atlantic International Corp. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp Receives Notification from Nasdaq Regarding Late Filing of Form 10-Q

    ENGLEWOOD CLIFFS, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp (NASDAQ:ATLN) (the "Company"), a global provider of outsourced services and workforce solutions, announced that it has received a notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), due to the delayed filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the "Form 10-Q") with the U.S. Securities and Exchange Commission (the "SEC"). The Rule requires Nasdaq-listed companies to timely file all required periodic financial reports wit

    6/2/26 5:00:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International's Circle8 Group Secures $380 Million Four-Year Technology Services Contract with Dutch Ministry of Education, Culture, and Science

    ENGLEWOOD CLIFFS, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, today announced that its wholly owned subsidiary, Circle8 Group, has secured a new four-year technology services contract with DUO Groningen, the executive agency of the Dutch Ministry of Education, Culture and Science. Under Dutch GAAP, the contract is valued at approximately $96 million1 per year, totaling roughly $380 million1 over four years. Under the new framework, Circle8 Group will provide senior specialists in application development, system development, test management, and security management. These services will s

    5/6/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International's Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands

    ENGLEWOOD CLIFFS, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp (NASDAQ:ATLN) today announced that Circle8 Netherlands, part of Circle8 Group, its European specialized IT and technology solutions subsidiary, ranked #5 among the largest workforce solutions firms in the Netherlands in the Flex Nieuws 2026 Top 100, rising from #14 in 2021. Circle8 Netherlands generated approximately $1.4 billion1 in annual gross revenue under Dutch GAAP and was the only top-ranked firm to achieve double-digit organic growth, at 15.2%2. The recognition validates Circle8's position as one of Europe's fastest-growing IT and technology solutions platforms and reinforces the foundation for

    4/30/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Expands its $1.2 Billion Revenue (Unaudited) Platform into AI, Cybersecurity, and Data Infrastructure Through Circle8

    ENGLEWOOD CLIFFS, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, today announced the strategic expansion of its $1.2 billion global technology and workforce revenue (unaudited) platform into artificial intelligence infrastructure, cybersecurity, and data infrastructure through Circle8 Group, its approximate $780 million European IT and technology business, leveraging enterprise and public-sector client relationships across Europe and North America. Atlantic expects these initiatives to support accelerated organic growth, materially increase revenue, and improve long-term EBITDA margins

    4/28/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Reports Fourth Quarter and Full Year 2025 Results

    ENGLEWOOD CLIFFS, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Following the combination with Circle8 Group, Atlantic is evolving into a scaled, transatlantic workforce solutions platform with a pro forma revenue run-rate exceeding $1 billion, combining U.S. industrial staffing operations with high-margin European technology talent capabilities. Management Commentary and Outlook "In 2025, Atlantic navigated through a transitional period, taking decisive actions to realign our cost structur

    4/16/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International to Attend 38th Annual ROTH Conference

    ENGLEWOOD CLIFFS, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, will be participating in the 38th Annual ROTH Conference being held March 22-24, 2026, at the Ritz Carlton in Dana Point, California. Chief Executive Officer Jeffrey Jagid will be representing the company and is available for one-on-one meetings on Monday, March 23rd. Mr. Jagid is expected to discuss Atlantic's recent acquisition of Circle8 and how its integration is strengthening the company's scale and competitive positioning across its outsourced services and workforce solutions platform. He will also address the launch

    3/16/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Appoints Gateway Group to Lead Investor Relations Program

    ENGLEWOOD CLIFFS, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, has appointed Gateway Group, a leading strategic corporate and financial communications advisory firm, to lead its investor relations program. Gateway will partner with Atlantic's leadership to strengthen its investor communications strategy and expand engagement within the financial community. The initiative will focus on sharpening the company's messaging and market positioning and expanding outreach to institutional investors and analysts through targeted engagement and conference participation. "Atlantic is entering an

    2/17/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Strengthens Management Team with Appointment of Kevin J. Murphy as Chief Financial Officer

    ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J. Murphy, CPA, as Chief Financial Officer, effective February 2, 2026, as the Company continues to scale its platform and integrate recent acquisitions. The appointment follows Atlantic International's acquisition of Circle8 Group, a leading European IT and technology staffing firm, creating a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenue. The transaction expanded Atlantic's geographic footprint into key European markets and added

    2/2/26 4:05:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Acquires Circle8 Group, Creating a $1.2 Billion Global Workforce Solutions Platform

    ENGLEWOOD CLIFFS, N.J., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing and workforce solutions, today announced the acquisition of Circle8 Group. The transaction creates a diversified global workforce solutions platform with $1.2 billion (unaudited) in annual revenue, uniting Atlantic's North American light industrial staffing operations with Circle8's leading European IT and technology talent business. Acquisition Summary Creates a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenueExpands Atlantic's geographic footprint into key European marketsAdds high-gro

    1/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Achieves Strong YTD Performance Through Operational Efficiencies and Substantial Revenue Growth

    ENGLEWOOD CLIFFS, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. today announced continued operational momentum in its third-quarter 2025 results, reflecting a meaningful shift in the company's financial trajectory and a significant improvement in year-to-date performance. For the first nine months of 2025, the company achieved $315.8 million in service revenue, supported by a record quarter that delivered $110.1 million in revenue, a 2.2% increase over the same period last year. This steady growth reflects sustained demand across a highly satisfied and referenceable client base. Atlantic International's financial turnaround is most evident in its bottom-line results

    11/17/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. SEC Filings

    View All

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    5/27/26 4:35:12 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form NT 10-Q filed by Atlantic International Corp.

    NT 10-Q - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    5/18/26 9:16:55 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form RW filed by Atlantic International Corp.

    RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    5/12/26 1:26:33 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 10-K filed by Atlantic International Corp.

    10-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    4/15/26 5:12:07 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    4/8/26 8:44:12 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    4/2/26 4:05:11 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form NT 10-K filed by Atlantic International Corp.

    NT 10-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    4/1/26 9:00:44 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets

    8-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    3/26/26 5:00:07 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form DEL AM filed by Atlantic International Corp.

    DEL AM - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    3/24/26 4:19:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form S-3 filed by Atlantic International Corp.

    S-3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    3/23/26 11:34:30 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:11:34 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:04:40 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:02:59 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 58% to 1,578,865 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/10/25 6:09:49 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 29% to 2,581,408 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/10/25 6:08:49 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 77% to 6,621,025 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/6/25 2:46:30 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pfeffer David converted options into 161,290 shares, increasing direct ownership by 10,542% to 162,820 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    3/16/26 6:42:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Franke Guus Paul Wilhelm claimed ownership of 12,516,070 shares (SEC Form 3)

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/10/26 4:05:29 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Murphy Kevin James

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    2/5/26 4:30:02 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Large owner Bressman Andrew exercised 500,000 shares at a strike of $1.33, increasing direct ownership by 8% to 7,003,971 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/7/26 5:34:58 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    General Counsel Tenore Michael exercised 1,202,901 shares at a strike of $1.33, increasing direct ownership by 188% to 1,843,725 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/7/26 4:49:07 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Chief Operating Officer Evelt Matthew

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/7/26 2:29:44 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Executive Officer Jagid Jeffrey M exercised 5,551,223 shares at a strike of $1.33, increasing direct ownership by 208% to 8,221,025 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/5/26 5:12:18 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    General Counsel Tenore Michael exercised 264,860 shares at a strike of $1.33, increasing direct ownership by 26% to 1,266,554 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    1/5/26 4:22:32 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Bressman Andrew claimed ownership of 6,503,971 shares (SEC Form 3)

    3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    9/2/25 4:30:22 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Chief Financial Officer Broderick Christopher

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/15/25 5:10:50 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Leadership Updates

    Live Leadership Updates

    View All

    Atlantic International Appoints Gateway Group to Lead Investor Relations Program

    ENGLEWOOD CLIFFS, N.J., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, has appointed Gateway Group, a leading strategic corporate and financial communications advisory firm, to lead its investor relations program. Gateway will partner with Atlantic's leadership to strengthen its investor communications strategy and expand engagement within the financial community. The initiative will focus on sharpening the company's messaging and market positioning and expanding outreach to institutional investors and analysts through targeted engagement and conference participation. "Atlantic is entering an

    2/17/26 8:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Strengthens Management Team with Appointment of Kevin J. Murphy as Chief Financial Officer

    ENGLEWOOD CLIFFS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of staffing and workforce solutions, today announced the appointment of Kevin J. Murphy, CPA, as Chief Financial Officer, effective February 2, 2026, as the Company continues to scale its platform and integrate recent acquisitions. The appointment follows Atlantic International's acquisition of Circle8 Group, a leading European IT and technology staffing firm, creating a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenue. The transaction expanded Atlantic's geographic footprint into key European markets and added

    2/2/26 4:05:00 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

    ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

    6/2/25 1:05:49 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Financials

    Live finance-specific insights

    View All

    Atlantic International Reports Fourth Quarter and Full Year 2025 Results

    ENGLEWOOD CLIFFS, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a global provider of outsourced services and workforce solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Following the combination with Circle8 Group, Atlantic is evolving into a scaled, transatlantic workforce solutions platform with a pro forma revenue run-rate exceeding $1 billion, combining U.S. industrial staffing operations with high-margin European technology talent capabilities. Management Commentary and Outlook "In 2025, Atlantic navigated through a transitional period, taking decisive actions to realign our cost structur

    4/16/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Acquires Circle8 Group, Creating a $1.2 Billion Global Workforce Solutions Platform

    ENGLEWOOD CLIFFS, N.J., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading provider of strategic staffing and workforce solutions, today announced the acquisition of Circle8 Group. The transaction creates a diversified global workforce solutions platform with $1.2 billion (unaudited) in annual revenue, uniting Atlantic's North American light industrial staffing operations with Circle8's leading European IT and technology talent business. Acquisition Summary Creates a diversified global workforce solutions platform with approximately $1.2 billion (unaudited) in annual revenueExpands Atlantic's geographic footprint into key European marketsAdds high-gro

    1/23/26 8:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

    Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

    3/28/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials